ERBB2 and gastric cancer: In addition, the same identified biomarker might have different roles in different tumors and with different drugs (e.g., HER2 mutations, amplifications, and overexpression represent specific biomarkers for lung, breast, and gastric cancer, respectively, requiring different testing methods accordingly).